Navigation Links
New peptide communication factor enabling bacteria to 'talk to each other' discovered
Date:10/29/2007

Jerusalem Discovery by Hebrew University of Jerusalem researchers of a new communication factor that enables bacteria to talk to each other and causes their death could have significant consequences leading to development of a new class of antibiotic medications.

Bacteria are traditionally considered unicellular organisms. However, increasing experimental evidence indicates that bacteria seldom behave as isolated organisms. Instead, they are members of a community in which the isolated organisms communicate among themselves, thereby manifesting some multi-cellular behaviors.

In an article published Friday (Oct. 26) in the journal Science, the Hebrew University scientists describe the new communication factor they have discovered that is produced by the intestinal bacteria Escherichia coli. The new factor is secreted by the bacteria and serves as a communication signal between single bacterial cells.

The research was carried out by a group headed by Prof. Hanna Engelberg-Kulka of the Department of Molecular Biology at the Hebrew University Hadassah Medical School. It includes Ph.D. student Ilana Kolodkin-Gal , and a previous Ph.D. student, Dr Ronen Hazan. In addition, the research included Dr Ariel Gaathon from the Facilities Unit of the Medical School.

The communication factor formed by Escherichia coli enables the activation of a built-in suicide module which is located on the bacterial chromosome and is esponsible for bacterial cell death under stressful conditions. Therefore, the new factor has been designated EDF (Extra-cellular Death Factor).

While suicidal cell death is counterproductive for the individual bacterial cell, it becomes effective for the bacterial community as a whole by the simultaneous action of a group of cells that are signaled by EDF. Under stressful conditions in which the EDF is activated, a major sub-population within the bacterial culture dies, allowing the survival of the population as a whole.

Understanding how the EDF functions may provide a lead for a new and more efficient class of antibiotics that specifically trigger bacterial cell death in the intestine bacteria Escherichia coli and probably in many other bacteria, including those pathogens that also carry the suicide module.

The discovered communication factor is a novel biological molecule, noted Prof Engelberg-Kulka. It is a peptide (a very small protein) that is produced by the bacteria. The chemical characterization of the new communication factor was particularly difficult for the researchers because of two main reasons: it is present in the bacterial culture in minute amounts, and the factor decomposes under the conditions that are routinely used during standard chemical characterization methods. Therefore, it was necessary to develop a new specific method. The research has also identified several bacterial genes that are involved in the generation of the communication factor, said Prof. Engelberg-Kulka. .


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem  
Source:Eurekalert

Related medicine news :

1. New Insight To The Role Of Peptide Signals
2. Biocon to colloborate for development of Oral peptide drugs for heart diseases.
3. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
4. Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says
5. Stress Protein Inactivation Cuts Alzheimers Peptide in Mice
6. Specific Imbalance Between Two Peptides may Cause Alzheimers
7. Appetite-regulating Peptides Influence Alcohol Cravings
8. Improved parent-physician communication to prevent hospitalizations for childhood asthma
9. Physician and Patient relationship strained due to non-verbal communications
10. Better Communication With FDA Could Speed Up Approval Of New Drugs
11. Doctoral communication gets wired badge: wireless communication.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New peptide communication factor enabling bacteria to 'talk to each other' discovered
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: